Medicare Enrolled
Dr. Bennett Myers, M.D.
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Myers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Myers?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Myers
Dr. Bennett Myers is a neurology specialist in Amherst, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Myers performed 63,319 Medicare services across 848 unique beneficiaries.
Between the years covered by Open Payments, Dr. Myers received a total of $454,594 from 99 pharmaceutical and/or device companies across 2007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Myers is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NY
$454,594 industry payments
Medicare Practice Summary
Medicare Utilization ↗63,319
Medicare services
Top 1% in NY for neurology
848
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
31,320 | $5 | $10 |
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
27,650 | $4 | $6 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,140 | $38 | $65 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
314 | $74 | $120 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 129 | $56 | $100 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
81 | $129 | $300 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
72 | $124 | $300 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
68 | $148 | $350 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
65 | $136 | $458 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
60 | $16 | $53 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
55 | $0 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $126 | $200 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
45 | $48 | $125 |
| New patient office visit, complex (60-74 min) | 45 | $153 | $275 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $83 | $150 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
37 | $216 | $425 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
28 | $48 | $75 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
28 | $91 | $220 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $70 | $100 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
19 | $96 | $265 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
18 | $182 | $375 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
15 | $103 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $103 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
98.5% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$454,594
Total received (2018-2024)
Avg $64,942/year across 7 years
Top 2% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
2,007
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$399,221 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$38,416 (8.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,957 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$88,211
2023
$62,867
2022
$74,992
2021
$30,435
2020
$36,337
2019
$70,898
2018
$90,854
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$32,645
Genentech USA, Inc.
$17,698
ABBVIE INC.
$14,891
Alexion Pharmaceuticals, Inc.
$7,234
Janssen Scientific Affairs, LLC
$3,675
Amgen Inc.
$3,300
UCB, Inc.
$2,818
EMD Serono, Inc.
$2,686
MDD US Operations, LLC
$850
TG Therapeutics, Inc.
$715
PFIZER INC.
$196
Genentech, Inc.
$142
REVANCE THERAPEUTICS, INC.
$140
Lundbeck LLC
$135
Novartis Pharmaceuticals Corporation
$118
Neurocrine Biosciences, Inc.
$118
CATALYST PHARMACEUTICALS, INC.
$86
GENZYME CORPORATION
$79
Nevro Corp.
$66
Alnylam Pharmaceuticals Inc.
$62
Grifols USA, LLC
$53
MITSUBISHI TANABE PHARMA AMERICA, INC.
$52
CSL Behring
$51
Lilly USA, LLC
$51
JAZZ PHARMACEUTICALS INC.
$48
Amneal Pharmaceuticals LLC
$34
Cycle Pharmaceuticals Inc
$32
Eisai Inc.
$30
Kyowa Kirin, Inc.
$24
Celgene Corporation
$24
LivaNova USA, Inc.
$23
Roche Diagnostics Corporation
$22
Averitas Pharma Inc.
$20
HARMONY BIOSCIENCES LLC
$18
Octapharma USA, Inc.
$18
Axsome Therapeutics, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Teva Pharmaceuticals USA, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 74.0% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$127,273
Biogen, Inc.
$114,341
ARGENX US, INC.
$55,894
ABBVIE INC.
$27,724
Alexion Pharmaceuticals, Inc.
$27,160
Novartis Pharmaceuticals Corporation
$25,488
EMD Serono, Inc.
$9,333
Horizon Therapeutics plc
$9,198
UCB, Inc.
$7,628
Teva Pharmaceuticals USA, Inc.
$7,251
Celgene Corporation
$7,219
Janssen Scientific Affairs, LLC
$4,620
Merz North America, Inc.
$3,947
Amgen Inc.
$3,479
Hoffmann-La Roche Limited
$2,894
F. Hoffmann-La Roche AG
$2,400
Merz Pharmaceuticals, LLC
$2,112
Genentech, Inc.
$2,110
AbbVie Inc.
$1,288
MDD US Operations, LLC
$1,033
Banner Life Sciences, LLC
$861
TG Therapeutics, Inc.
$715
Neurocrine Biosciences, Inc.
$680
Avanir Pharmaceuticals, Inc.
$673
PFIZER INC.
$488
ACADIA Pharmaceuticals Inc
$479
Kyowa Kirin, Inc.
$473
Alnylam Pharmaceuticals Inc.
$424
GENZYME CORPORATION
$383
MITSUBISHI TANABE PHARMA AMERICA, INC.
$348
Lundbeck LLC
$337
Adamas Pharmaceuticals, Inc.
$336
Roche Products Limited
$327
GE HEALTHCARE
$286
Nevro Corp.
$265
Otsuka America Pharmaceutical, Inc.
$264
Janssen Pharmaceuticals, Inc
$236
Allergan, Inc.
$223
Allergan Inc.
$217
CSL Behring
$204
Lilly USA, LLC
$179
CATALYST PHARMACEUTICALS, INC.
$172
US WorldMeds, LLC
$170
Biohaven Pharmaceutical Holding Company Ltd.
$170
MERZ NORTH AMERICA, INC.
$160
REVANCE THERAPEUTICS, INC.
$140
Eisai Inc.
$138
E.R. Squibb & Sons, L.L.C.
$134
Abbott Laboratories
$128
Mallinckrodt LLC
$128
Mallinckrodt Hospital Products Inc.
$126
SK Life Science, Inc.
$123
Ipsen Biopharmaceuticals, Inc
$121
Mallinckrodt Enterprises LLC
$112
EISAI INC.
$109
GRT US Holding, Inc.
$107
Greenwich Biosciences, Inc.
$107
Akcea Therapeutics, Inc.
$106
Amneal Pharmaceuticals LLC
$98
JAZZ PHARMACEUTICALS INC.
$92
SANOFI-AVENTIS U.S. LLC
$90
GE HealthCare
$84
Medtronic USA, Inc.
$81
ARBOR PHARMACEUTICALS, INC.
$77
Grifols USA, LLC
$73
TG THERAPEUTICS, INC.
$62
Acorda Therapeutics, Inc
$62
Octapharma USA, Inc.
$61
Biohaven Pharmaceuticals, Inc.
$55
AbbVie, Inc.
$45
Mitsubishi Tanabe Pharma America, Inc.
$45
Harmony Biosciences LLC
$43
Upsher-Smith Laboratories LLC
$40
Catalyst Pharmaceuticals, Inc.
$37
UPSHER-SMITH LABORATORIES LLC
$36
Endo Pharmaceuticals Inc.
$33
Cycle Pharmaceuticals Inc
$32
SCILEX PHARMACEUTICALS INC.
$29
Axsome Therapeutics, Inc.
$28
Supernus Pharmaceuticals, Inc.
$27
Jazz Pharmaceuticals Inc.
$24
LivaNova USA, Inc.
$23
Roche Diagnostics Corporation
$22
Sarepta Therapeutics, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Averitas Pharma Inc.
$20
Xeris Pharmaceuticals, Inc.
$20
Scilex Pharmaceuticals Inc.
$19
HARMONY BIOSCIENCES LLC
$18
Sobi, Inc
$18
Azurity Pharmaceuticals, Inc.
$17
AstraZeneca Pharmaceuticals LP
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
IDORSIA PHARMACEUTICALS US INC
$13
Amylyx Pharmaceuticals, Inc.
$13
BANNER LIFE SCIENCES, LLC
$13
Avion Pharmaceuticals
$12
PTC Therapeutics, Inc.
$12
Assertio Therapeutics, Inc.
$12
Top 3 companies account for 65.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AIMOVIG · AJOVY · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Adempas · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bafiertam · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · DAXXIFY · DUOPA · DYSPORT · Dayvigo · Dhivy · Duopa · EMFLAZA · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · Exondys 51 · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neuromodulation Dspsbls and Accs · Non-Covered Product · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OCTRODE · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Omnia · Ongentys · Ormalvi · Ozanimod · PANZYGA · PLEGRIDY · POMPE - DISEASE · Ponvory · Privigen · Proclaim IPG · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · RELYVRIO · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Senza · Soliris · Sunosi · TECFIDERA · TEGSEDI · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · Wakix · XADAGO · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq · Zinbryta · cobas pro ISE analytical unit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Myers is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Myers experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Myers performed 31,320 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Myers receive payments from pharmaceutical companies?
Yes. Dr. Myers received a total of $454,594 from 99 companies across 2,007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Myers's costs compare to other neurologists in Amherst?
Dr. Myers's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Myers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ARGENX US, INC. Payments to Doctors
See all physicians who received payments from ARGENX US, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology